Meeting
2019 ASCO Annual Meeting
Circulating cell-free DNA (cfDNA) levels and fragmentation pattern can distinguish nonmuscle invasive (NMI) from muscle-invasive (MI) and metastatic (met) bladder cancer (BC).
Authors
Jaleh Fallah
Cleveland Clinic Foundation, Cleveland, OH
Jaleh Fallah , Shinjini Ganguly , Hong Li , Wei (Auston) Wei , Aysegul Balyimez , Thirunavukkarasu Sitalaximi , C. Marcela Diaz-Montero , Patricia A. Rayman , Marcelo Lamenza , Priscilla Dann , Donna Company , Rahul D. Tendulkar , Mohamed Abazeed , Jorge A. Garcia , Moshe Chaim Ornstein , Brian I. Rini , Byron H Lee , Petros Grivas , Omar Y. Mian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Bladder Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 4523)
DOI
10.1200/JCO.2019.37.15_suppl.4523
Abstract #
4523
Poster Bd #
349
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Association of cell-free DNA (cfDNA) levels with myeloid-derived suppressor cells (MDSC) levels in blood of patients (pts) with muscle invasive (MI) and metastatic (met) bladder cancer (BC).
First Author: Jaleh Fallah
Poster
2018 Genitourinary Cancers Symposium
Evaluating cell cycle progression score as a prognostic marker for non-muscle invasive bladder cancer (NMIBC).
First Author: Christopher J. Weight
Poster
2018 Genitourinary Cancers Symposium
Defining the DNA damage repair (DDR) genomic landscape of urothelial carcinoma of the bladder (UCB).
First Author: Shawn Dason
First Author: Francois Audenet